Charles River Laboratories International (CRL) Interest & Investment Income (2009 - 2025)

Charles River Laboratories International (CRL) has reported Interest & Investment Income for 17 consecutive years, with $1.0 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Interest & Investment Income fell 44.58% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $4.9 million (down 42.39% YoY), while the FY2025 annual figure was $4.9 million, down 42.39% from the prior year.
• Interest & Investment Income came in at $1.0 million for Q4 2025 at Charles River Laboratories International, down from $1.4 million in the prior quarter.
• The five-year high for Interest & Investment Income was $3.0 million in Q2 2024, with the low at $35000.0 in Q1 2021.
• Average Interest & Investment Income over 5 years is $1.0 million, with a median of $1.1 million recorded in 2025.
• Across the five-year window, Interest & Investment Income slumped 88.92% in 2021 and jumped 1025.41% in 2023, its largest moves.
• Year by year, Interest & Investment Income stood at $309000.0 in 2021, then grew by 11.0% to $343000.0 in 2022, then jumped by 363.85% to $1.6 million in 2023, then rose by 15.34% to $1.8 million in 2024, then slumped by 44.58% to $1.0 million in 2025.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $1.0 million, $1.4 million, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.